![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TPO |
Gene summary for TPO |
![]() |
Gene information | Species | Human | Gene symbol | TPO | Gene ID | 7173 |
Gene name | thyroid peroxidase | |
Gene Alias | MSA | |
Cytomap | 2p25.3 | |
Gene Type | protein-coding | GO ID | GO:0002376 | UniProtAcc | P07202 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7173 | TPO | Adj_PTCwithHT_6 | Human | Thyroid | HT | 2.93e-61 | -1.54e+00 | 0.02 |
7173 | TPO | Adj_PTCwithHT_8 | Human | Thyroid | HT | 8.95e-08 | -5.95e-01 | 0.0267 |
7173 | TPO | PTCwithHT_1 | Human | Thyroid | HT | 5.57e-25 | -1.57e+00 | 0.0238 |
7173 | TPO | PTCwithHT_6 | Human | Thyroid | HT | 1.34e-57 | -1.47e+00 | 0.02 |
7173 | TPO | PTCwithHT_8 | Human | Thyroid | HT | 6.02e-59 | -1.51e+00 | 0.0351 |
7173 | TPO | PTCwithoutHT_2 | Human | Thyroid | PTC | 8.90e-62 | -1.52e+00 | 0.0419 |
7173 | TPO | PTCwithoutHT_7 | Human | Thyroid | PTC | 1.57e-20 | -1.45e+00 | 0.0381 |
7173 | TPO | male-WTA | Human | Thyroid | PTC | 3.68e-25 | -8.76e-01 | 0.1037 |
7173 | TPO | female-WTA | Human | Thyroid | PTC | 1.38e-04 | -7.84e-01 | 0.0726 |
7173 | TPO | PTC01 | Human | Thyroid | PTC | 2.83e-66 | -1.37e+00 | 0.1899 |
7173 | TPO | PTC04 | Human | Thyroid | PTC | 2.36e-33 | -4.69e-01 | 0.1927 |
7173 | TPO | PTC05 | Human | Thyroid | PTC | 6.70e-18 | -1.31e+00 | 0.2065 |
7173 | TPO | PTC06 | Human | Thyroid | PTC | 9.87e-11 | -6.68e-01 | 0.2057 |
7173 | TPO | PTC07 | Human | Thyroid | PTC | 6.58e-10 | -3.86e-01 | 0.2044 |
7173 | TPO | ATC08 | Human | Thyroid | ATC | 2.88e-23 | -1.55e+00 | 0.0541 |
7173 | TPO | ATC09 | Human | Thyroid | ATC | 4.93e-26 | -1.57e+00 | 0.2871 |
7173 | TPO | ATC11 | Human | Thyroid | ATC | 1.02e-07 | -1.57e+00 | 0.3386 |
7173 | TPO | ATC12 | Human | Thyroid | ATC | 4.01e-71 | -1.57e+00 | 0.34 |
7173 | TPO | ATC13 | Human | Thyroid | ATC | 1.59e-68 | -1.57e+00 | 0.34 |
7173 | TPO | ATC1 | Human | Thyroid | ATC | 2.78e-22 | -1.57e+00 | 0.2878 |
Page: 1 2 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Thyroid | ![]() | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis | ||
PTC: Papillary thyroid cancer |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000697930 | Thyroid | HT | response to oxidative stress | 81/1272 | 446/18723 | 2.53e-16 | 1.17e-13 | 81 |
GO:000963627 | Thyroid | HT | response to toxic substance | 50/1272 | 262/18723 | 2.25e-11 | 3.75e-09 | 50 |
GO:199074827 | Thyroid | HT | cellular detoxification | 31/1272 | 116/18723 | 2.29e-11 | 3.75e-09 | 31 |
GO:009875420 | Thyroid | HT | detoxification | 36/1272 | 152/18723 | 2.63e-11 | 4.07e-09 | 36 |
GO:009723727 | Thyroid | HT | cellular response to toxic substance | 32/1272 | 124/18723 | 3.00e-11 | 4.51e-09 | 32 |
GO:009886926 | Thyroid | HT | cellular oxidant detoxification | 26/1272 | 101/18723 | 2.23e-09 | 2.26e-07 | 26 |
GO:004274315 | Thyroid | HT | hydrogen peroxide metabolic process | 17/1272 | 58/18723 | 1.73e-07 | 9.32e-06 | 17 |
GO:007259320 | Thyroid | HT | reactive oxygen species metabolic process | 39/1272 | 239/18723 | 2.90e-07 | 1.38e-05 | 39 |
GO:00427447 | Thyroid | HT | hydrogen peroxide catabolic process | 11/1272 | 32/18723 | 4.65e-06 | 1.48e-04 | 11 |
GO:00065759 | Thyroid | HT | cellular modified amino acid metabolic process | 28/1272 | 188/18723 | 7.21e-05 | 1.31e-03 | 28 |
GO:0006590 | Thyroid | HT | thyroid hormone generation | 7/1272 | 20/18723 | 2.32e-04 | 3.29e-03 | 7 |
GO:0042403 | Thyroid | HT | thyroid hormone metabolic process | 8/1272 | 27/18723 | 3.07e-04 | 4.08e-03 | 8 |
GO:0006979113 | Thyroid | PTC | response to oxidative stress | 234/5968 | 446/18723 | 6.97e-20 | 9.77e-18 | 234 |
GO:0072593110 | Thyroid | PTC | reactive oxygen species metabolic process | 108/5968 | 239/18723 | 1.02e-05 | 1.13e-04 | 108 |
GO:0009636111 | Thyroid | PTC | response to toxic substance | 115/5968 | 262/18723 | 2.70e-05 | 2.63e-04 | 115 |
GO:000657513 | Thyroid | PTC | cellular modified amino acid metabolic process | 85/5968 | 188/18723 | 8.29e-05 | 7.01e-04 | 85 |
GO:1990748112 | Thyroid | PTC | cellular detoxification | 56/5968 | 116/18723 | 1.63e-04 | 1.26e-03 | 56 |
GO:0097237112 | Thyroid | PTC | cellular response to toxic substance | 59/5968 | 124/18723 | 1.83e-04 | 1.39e-03 | 59 |
GO:0098869111 | Thyroid | PTC | cellular oxidant detoxification | 49/5968 | 101/18723 | 3.52e-04 | 2.41e-03 | 49 |
GO:00065901 | Thyroid | PTC | thyroid hormone generation | 14/5968 | 20/18723 | 5.24e-04 | 3.37e-03 | 14 |
Page: 1 2 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TPO | SNV | Missense_Mutation | novel | c.1450N>A | p.Val484Met | p.V484M | P07202 | protein_coding | deleterious(0) | probably_damaging(0.985) | TCGA-IN-A6RS-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TPO | SNV | Missense_Mutation | rs150812908 | c.502G>A | p.Ala168Thr | p.A168T | P07202 | protein_coding | deleterious(0.03) | probably_damaging(0.968) | TCGA-KB-A93G-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TPO | SNV | Missense_Mutation | rs752390603 | c.2435N>T | p.Ala812Val | p.A812V | P07202 | protein_coding | deleterious(0.01) | possibly_damaging(0.889) | TCGA-SW-A7EA-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
TPO | SNV | Missense_Mutation | rs560609999 | c.1592N>A | p.Arg531His | p.R531H | P07202 | protein_coding | deleterious(0.01) | benign(0.027) | TCGA-VQ-A91K-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | CR |
TPO | SNV | Missense_Mutation | rs201782331 | c.2155N>A | p.Glu719Lys | p.E719K | P07202 | protein_coding | tolerated(0.22) | benign(0.003) | TCGA-VQ-A91Y-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | fluorouracil | PD |
TPO | SNV | Missense_Mutation | rs368181428 | c.2704N>A | p.Val902Ile | p.V902I | P07202 | protein_coding | tolerated_low_confidence(0.4) | benign(0.005) | TCGA-VQ-A924-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |
TPO | deletion | Frame_Shift_Del | rs760307139 | c.2421delC | p.Cys808AlafsTer24 | p.C808Afs*24 | P07202 | protein_coding | TCGA-BR-6852-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
TPO | deletion | Frame_Shift_Del | novel | c.607delN | p.Pro204ArgfsTer5 | p.P204Rfs*5 | P07202 | protein_coding | TCGA-BR-8382-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
TPO | deletion | Frame_Shift_Del | rs760307139 | c.2415delN | p.Cys808AlafsTer24 | p.C808Afs*24 | P07202 | protein_coding | TCGA-BR-8382-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | ||
TPO | SNV | Missense_Mutation | rs749796672 | c.1951N>T | p.Pro651Ser | p.P651S | P07202 | protein_coding | deleterious(0) | probably_damaging(0.997) | TCGA-EM-A4FN-01 | Thyroid | thyroid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | Methimazole | METHIMAZOLE | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | Propylthiouracil | PROPYLTHIOURACIL | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | inhibitor | 178103263 | PROPYLTHIOURACIL | |
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | PROPYLTHIOURACIL | PROPYLTHIOURACIL | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | RETINOIC ACID | 8396187 | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | Carbimazole | CARBIMAZOLE | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | PROPYLTHIOURACIL | PROPYLTHIOURACIL | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | METHIMAZOLE | METHIMAZOLE | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | CARBIMAZOLE | CARBIMAZOLE | ||
7173 | TPO | ENZYME, DRUGGABLE GENOME, CELL SURFACE | CARBIMAZOLE | CARBIMAZOLE |
Page: 1 2 |